Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu • (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.
This work is a step forward in understanding early molecular changes that influence the development of addiction, and may have application to the role of similar gene programs that mediate other types of behavior, memory formation or neuropsychiatric disorders.
This study was done in mice and with a novel, tissue-engineered, three-dimensional breast cancer mimetic system.
This mouse study looked at a group of immune cells called innate-like B-1 B cells.
FASEB is the largest coalition of biological and biomedical research associations in the United States.
Injections of two chemicals in a slow-release form significantly reduced the size of dead heart tissue and improved the function of the left ventricle.
This novel finding will enable experimental studies to determine whether and how these microbes play a role in triggering the disease.
A mouse model and previous studies suggest that genetic intervention in SHANK3-related ASD may be most effective earlier in development.
Results show that retinitis pigmentosa 59 may not be a congenital disorder of glycosylation, as was long assumed.
Everyone was fast this spring: the businesses that contributed to the fund, the scientists and physicians who crafted research proposals, and the senior School of Medicine researchers who chose which proposals got money.
The complement system is part of the body’s immune system to fight pathogens and remove cell debris. Its role in two autoimmune diseases and a mental disorder is a surprise.